Neogenomics Inc’s recent filing unveils that its Pres & Chief Operating Officer Stone Warren acquired Company’s shares for reported $48895.0 on May 12 ’25. In the deal valued at $8.58 per share,5,700 shares were bought. As a result of this transaction, Stone Warren now holds 108,280 shares worth roughly $0.87 million.
Then, TETRAULT LYNN A. bought 7,000 shares, generating $56,974 in total proceeds. Upon buying the shares at $8.14, the Director now owns 7,000 shares.
Before that, KANOVSKY STEPHEN M bought 4,000 shares. Neogenomics Inc shares valued at $31,124 were divested by the Director at a price of $7.78 per share. As a result of the transaction, KANOVSKY STEPHEN M now holds 40,090 shares, worth roughly $0.32 million.
Guggenheim initiated its Neogenomics Inc [NEO] rating to a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in late April from “an Outperform” to “a Market perform”. The Benchmark Company also remained covering NEO and has decreased its forecast on January 13, 2025 with a “Hold” recommendation from previously “Buy” rating. Jefferies started covering the stock on December 10, 2024. It rated NEO as “a Buy”.
Price Performance Review of NEO
On Monday, Neogenomics Inc [NASDAQ:NEO] saw its stock fall -0.62% to $8.06. Over the last five days, the stock has lost -5.29%. Neogenomics Inc shares have fallen nearly -51.09% since the year began. Nevertheless, the stocks have fallen -46.73% over the past one year.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-04-30, dropping by 87636.0 shares to a total of 4.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 4.84 million shares. There was a decline of -1.85%, which implies that there is a negative sentiment for the stock.
